US FDA’s Califf Acknowledges There Is ‘Price To Pay’ For Missed Inspections

 
• By Brenda Sandburg

Commissioner Califf is questioned about the backlog of inspections and fact FDA staff are continuing to work remotely at Senate HELP Committee hearing. Senator Burr promises to be a roadblock to emergency COVID-19 funding.

COVID funding
Congress questions US FDA policies in dispute over COVID-19 emergency funding • Source: Shutterstock

More from Manufacturing

More from Compliance